(Q40168057)

18 September 2017

title

Therapeutic challenges for systemic sclerosis: facts and future targets (English)

1 reference

18 September 2017

M Cerinic Matucci

1

1 reference

18 September 2017

Angela Del Rosso

2

1 reference

18 September 2017

Perfetto Federico

3

1 reference

18 September 2017

Riccardo Livi

4

1 reference

18 September 2017

Ginevra Fiori

5

1 reference

18 September 2017

Francesca Bartoli

6

1 reference

18 September 2017

Jelena Blagojevic

7

1 reference

18 September 2017

Alessio Tempestini

8

1 reference

18 September 2017

Alberto Pignone

9

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Annals of the New York Academy of Sciences

18 September 2017

published in

1 reference

18 September 2017

volume

1110

1 reference

18 September 2017

page(s)

448-454

1 reference

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Effects of lipo-prostaglandin E1 on pulmonary hemodynamics and clinical outcomes in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Imatinib for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.047

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1423.047

1 reference

18 September 2017

1 reference